Free webinar: The Keys to Comprehensive Astigmatism Management
Managing astigmatism may be one of the most limiting steps for optimal refactive results following cataract surgery. Why is this, and what are the keys to effectively managing it?
In the third and final installment of Ophthalmology Times' webinar series sponsored by Abbott Medical Optics, you'll come away with the steps to manage astigmatism and more:
  • Properly assessing astigmatism
  • Asking patients the right questions
  • Pre-operative diagnostics
  • The surgical approach
  • Why the TECNIS® Toric IOL is preferred
  • The latest innovations
Webinar: The Keys to Comprehensive Astigmatism Management for Cataract Patients
Date: Tuesday, October 25, 2016
Time: 12 PM (ET) / 9 AM (PT)
Register now!
This resource is brought to you by Ophthalmology Times, sponsored by Abbott Medical Optics, and may contain promotional material.
INDICATIONS AND IMPORTANT SAFETY INFORMATION for the TECNIS Toric 1-Piece IOL

Rx Only

INDICATIONS: The TECNIS Toric 1-Piece posterior chamber lenses are indicated for the visual correction of aphakia and pre-existing corneal astigmatism of one diopter or greater in adult patients with or without presbyopia in whom a cataractous lens has been removed by phacoemulsification and who desire improved uncorrected distance vision, reduction in residual refractive cylinder, and increased spectacle independence for distance vision. The device is intended to be placed in the capsular bag. IMPORTANT SAFETY INFORMATION: Rotation can reduce astigmatic correction. Misalignment greater than 30° may induce refractive error. Accurate keratometry, biometry and www.TecnisToricCalc.com are recommended to optimize visual outcomes. Weigh the potential risk/benefit ratio that could increase pre-existing complications or impact patient outcomes. Variability in any preoperative measurements can influence outcomes.

ATTENTION: Reference the Directions for Use labeling for a complete listing of Indications and Important Safety Information.

TECNIS is a trademark owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates.
{{ view_as_page_section }}
This email was sent by:
{{ site_settings.company_name }}, {{ site_settings.company_street_address_1 }}, {{ site_settings.company_city }}, {{ site_settings.company_state }} {{ site_settings.company_zip }}
{{unsubscribe_section }}
PP2016CT1066